ArticleClinical and experimental hepatology2025
Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients.
Inas M Moaz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.